메뉴 건너뛰기




Volumn 152, Issue 5, 2008, Pages 723-727

Enzyme Replacement Therapy for Mucopolysaccharidoses: Opinions of Patients and Families

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; GALSULFASE;

EID: 41849131481     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.10.015     Document Type: Article
Times cited : (15)

References (25)
  • 1
  • 2
    • 0000869162 scopus 로고    scopus 로고
    • The mucopolysaccharidoses
    • Scriver C.R., Beaudet A.L., Sly W.S., et al. (Eds), McGraw-Hill, New York
    • Neufeld E.F., and Muenzer J. The mucopolysaccharidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., et al. (Eds). The metabolic and molecular bases of inherited diseases (2001), McGraw-Hill, New York 3421-3452
    • (2001) The metabolic and molecular bases of inherited diseases , pp. 3421-3452
    • Neufeld, E.F.1    Muenzer, J.2
  • 3
    • 27844491492 scopus 로고    scopus 로고
    • Current and emerging therapies for the lysosomal storage disorders
    • Pastores G.M., and Barnett N.L. Current and emerging therapies for the lysosomal storage disorders. Expert Opin Emerg Drugs 10 (2005) 891-902
    • (2005) Expert Opin Emerg Drugs , vol.10 , pp. 891-902
    • Pastores, G.M.1    Barnett, N.L.2
  • 4
    • 33747209013 scopus 로고    scopus 로고
    • A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
    • Muenzer J., Wraith J.E., Beck M., Giugliani R., Harmatz P., Eng C.M., et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 8 (2006) 465-473
    • (2006) Genet Med , vol.8 , pp. 465-473
    • Muenzer, J.1    Wraith, J.E.2    Beck, M.3    Giugliani, R.4    Harmatz, P.5    Eng, C.M.6
  • 5
    • 0035999743 scopus 로고    scopus 로고
    • Enzyme replacement therapy for the mucopolysaccharide storage disorders
    • Kakkis E.D. Enzyme replacement therapy for the mucopolysaccharide storage disorders. Expert Opin Investig Drugs 11 (2002) 675-685
    • (2002) Expert Opin Investig Drugs , vol.11 , pp. 675-685
    • Kakkis, E.D.1
  • 6
    • 33744978567 scopus 로고    scopus 로고
    • Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
    • Harmatz P., Giugliani R., Schwartz I., Guffon N., Teles E.L., Miranda M.C., et al. Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 148 (2006) 533-539
    • (2006) J Pediatr , vol.148 , pp. 533-539
    • Harmatz, P.1    Giugliani, R.2    Schwartz, I.3    Guffon, N.4    Teles, E.L.5    Miranda, M.C.6
  • 7
    • 0025666525 scopus 로고
    • The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment
    • Hopwood J.J., and Morris C.P. The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol Biol Med 7 (1990) 381-404
    • (1990) Mol Biol Med , vol.7 , pp. 381-404
    • Hopwood, J.J.1    Morris, C.P.2
  • 9
    • 0035000479 scopus 로고    scopus 로고
    • Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties
    • Wraith J.E. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. J Inherit Metab Dis 24 (2001) 245-250
    • (2001) J Inherit Metab Dis , vol.24 , pp. 245-250
    • Wraith, J.E.1
  • 10
    • 2342666229 scopus 로고    scopus 로고
    • Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)
    • Wraith J.E., Clarke L.A., Beck M., Kolodny E.H., Pastores G.M., Muenzer J., et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144 (2004) 581-588
    • (2004) J Pediatr , vol.144 , pp. 581-588
    • Wraith, J.E.1    Clarke, L.A.2    Beck, M.3    Kolodny, E.H.4    Pastores, G.M.5    Muenzer, J.6
  • 12
    • 33846899175 scopus 로고    scopus 로고
    • A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)
    • Muenzer J., Gucsavas-Calikoglu M., McCandless S.E., Schuetz T.J., and Kimura A. A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 90 (2007) 329-337
    • (2007) Mol Genet Metab , vol.90 , pp. 329-337
    • Muenzer, J.1    Gucsavas-Calikoglu, M.2    McCandless, S.E.3    Schuetz, T.J.4    Kimura, A.5
  • 13
    • 33747209013 scopus 로고    scopus 로고
    • A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
    • Muenzer J., Wraith J.E., Beck M., Giugliani R., Harmatz P., Eng C.M., et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 8 (2006) 465-473
    • (2006) Genet Med , vol.8 , pp. 465-473
    • Muenzer, J.1    Wraith, J.E.2    Beck, M.3    Giugliani, R.4    Harmatz, P.5    Eng, C.M.6
  • 14
    • 1542669902 scopus 로고    scopus 로고
    • Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    • Harmatz P., Whitley C.B., Waber L., Pais R., Steiner R., Plecko B., et al. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr 144 (2004) 574-580
    • (2004) J Pediatr , vol.144 , pp. 574-580
    • Harmatz, P.1    Whitley, C.B.2    Waber, L.3    Pais, R.4    Steiner, R.5    Plecko, B.6
  • 15
    • 27744493202 scopus 로고    scopus 로고
    • Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase
    • Harmatz P., Ketteridge D., Giugliani R., Guffon N., Teles E.L., Miranda M.C., et al. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics 115 (2005) e681-e689
    • (2005) Pediatrics , vol.115
    • Harmatz, P.1    Ketteridge, D.2    Giugliani, R.3    Guffon, N.4    Teles, E.L.5    Miranda, M.C.6
  • 17
    • 17744388985 scopus 로고    scopus 로고
    • Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns
    • Wang D., Eadala B., Sadilek M., Chamoles N.A., Turecek F., Scott C.R., et al. Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns. Clin Chem 51 (2005) 898-900
    • (2005) Clin Chem , vol.51 , pp. 898-900
    • Wang, D.1    Eadala, B.2    Sadilek, M.3    Chamoles, N.A.4    Turecek, F.5    Scott, C.R.6
  • 18
    • 33845966431 scopus 로고    scopus 로고
    • Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease)
    • Wang D., Wood T., Sadilek M., Scott C.R., Turecek F., and Gelb M.H. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease). Clin Chem 53 (2007) 137-140
    • (2007) Clin Chem , vol.53 , pp. 137-140
    • Wang, D.1    Wood, T.2    Sadilek, M.3    Scott, C.R.4    Turecek, F.5    Gelb, M.H.6
  • 19
    • 34248344253 scopus 로고    scopus 로고
    • Newborn screening for mucopolysaccharidoses: opinions of patients and their families
    • Hayes I.M., Collins V., Sahhar M., Wraith J.E., and Delatycki M.B. Newborn screening for mucopolysaccharidoses: opinions of patients and their families. Clin Genet 71 (2007) 446-450
    • (2007) Clin Genet , vol.71 , pp. 446-450
    • Hayes, I.M.1    Collins, V.2    Sahhar, M.3    Wraith, J.E.4    Delatycki, M.B.5
  • 20
    • 2942588994 scopus 로고    scopus 로고
    • Enzyme replacement and enhancement therapies for lysosomal diseases
    • Desnick R.J. Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27 (2004) 385-410
    • (2004) J Inherit Metab Dis , vol.27 , pp. 385-410
    • Desnick, R.J.1
  • 21
    • 2342666229 scopus 로고    scopus 로고
    • Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)
    • Wraith J.E., Clarke L.A., Beck M., Kolodny E.H., Pastores G.M., Muenzer J., et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144 (2004) 581-588
    • (2004) J Pediatr , vol.144 , pp. 581-588
    • Wraith, J.E.1    Clarke, L.A.2    Beck, M.3    Kolodny, E.H.4    Pastores, G.M.5    Muenzer, J.6
  • 22
    • 33745506072 scopus 로고    scopus 로고
    • Lysosomal storage diseases: natural history and ethical and economic aspects
    • Beutler E. Lysosomal storage diseases: natural history and ethical and economic aspects. Mol Genet Metab 88 (2006) 208-215
    • (2006) Mol Genet Metab , vol.88 , pp. 208-215
    • Beutler, E.1
  • 23
    • 0029914486 scopus 로고    scopus 로고
    • The cost of treating Gaucher disease
    • Beutler E. The cost of treating Gaucher disease. Nat Med 2 (1996) 523-524
    • (1996) Nat Med , vol.2 , pp. 523-524
    • Beutler, E.1
  • 24
    • 23844490950 scopus 로고    scopus 로고
    • Copper-replacement treatment for symptomatic Menkes disease: ethical considerations
    • Sheela S.R., Latha M., Liu P., Lem K., and Kaler S.G. Copper-replacement treatment for symptomatic Menkes disease: ethical considerations. Clin Genet 68 (2005) 278-283
    • (2005) Clin Genet , vol.68 , pp. 278-283
    • Sheela, S.R.1    Latha, M.2    Liu, P.3    Lem, K.4    Kaler, S.G.5
  • 25
    • 0031670398 scopus 로고    scopus 로고
    • Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease
    • Elstein D., Abrahamov A., and Zimran A. Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease. Clin Genet 54 (1998) 179-184
    • (1998) Clin Genet , vol.54 , pp. 179-184
    • Elstein, D.1    Abrahamov, A.2    Zimran, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.